NCT00038948View on ClinicalTrials.gov

Study Comparing Conversion to Sirolimus vs. Continued Use of Calcineurin Inhibitors in Kidney Transplant Recipients

PHASE3CompletedINTERVENTIONAL

Enrollment

830

Participants

Timeline

Start Date

January 31, 2002

Primary Completion Date

May 31, 2008

Study Completion Date

May 31, 2008

Conditions

Renal Transplantation

Interventions

DRUG

Sirolimus

Sirolimus, Cyclosporine A \& Tacrolimus are concentration controlled

DRUG

tacrolimus

DRUG

Cyclosporine A

All Listed Sponsors

lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00038948 - Study Comparing Conversion to Sirolimus vs. Continued Use of Calcineurin Inhibitors in Kidney Transplant Recipients | Biotech Hunter | Biotech Hunter